androstenedione has been researched along with Disease Exacerbation in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audenet, F; Murez, T; Neuzillet, Y; Ripert, T; Villers, A | 1 |
| Arai, S; Hashimoto, K; Honma, S; Ito, K; Kashiwagi, B; Miyashiro, Y; Nakamura, Y; Sasano, H; Sekine, Y; Shibata, Y; Suzuki, K; Tomaru, Y; Uei, T | 1 |
| Jiang, Z; Liu, X; Song, S; Wang, T; Wu, S; Yu, J | 1 |
| Arleth, S; Bechtold, S; Bittmann, I; Bonfig, W; Kammer, B; Noelle, V; Raile, K; Schwarz, HP | 1 |
| Burton, G; Kleeberg, U; Mauriac, L; Osborne, CK; Robertson, JF; Vergote, I | 1 |
| Demmel, B; Herrmann, M; Kees, F; Schedel, J; Schmidt, M; Schölmerich, J; Straub, RH; Weidler, C | 1 |
| Agostara, B; Bronte, G; Campisi, I; Carruba, G; Castagnetta, L; Cocciadiferro, L; Granata, OM; Polito, L; Rizzo, S; Saetta, A | 1 |
| Blanchett, D; Bondarenko, IN; Goss, P; Langecker, P; Manikhas, GN; Miller, WH; Pendergrass, KB | 1 |
| Garbe, C; Gee, J; Mac Neil, S; Miller, JG; Price, A; Wagner, M | 1 |
| Coombes, RC; Harper-Wynne, C | 1 |
| Carlini, P; Casali, A; Cognetti, F; De Marco, S; Fabi, A; Frassoldati, A; Nardi, M; Paoloni, F; Papaldo, P; Ruggeri, EM | 1 |
2 review(s) available for androstenedione and Disease Exacerbation
| Article | Year |
|---|---|
[CYP17A1 inhibitors in prostate cancer: mechanisms of action independent of the androgenic pathway].
Topics: Abiraterone Acetate; Adjuvants, Immunologic; Androgens; Androstadienes; Androstenedione; Antineoplastic Agents; Dehydroepiandrosterone; Disease Progression; Humans; Male; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase; Treatment Outcome | 2013 |
Sex steroids, carcinogenesis, and cancer progression.
Topics: Adsorption; Androstenedione; Animals; Breast Neoplasms; Catalysis; Catechols; Cell Line, Tumor; Chromatography, High Pressure Liquid; Disease Progression; Estradiol; Estrogens; Humans; In Vitro Techniques; Ions; Kinetics; Models, Biological; Neoplasms; Steroids; Time Factors | 2004 |
4 trial(s) available for androstenedione and Disease Exacerbation
| Article | Year |
|---|---|
[Clinical trial of lentaron for postmenopausal patients with advanced breast cancer].
Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Disease Progression; Female; Humans; Neoplasm Metastasis; Neoplasm Staging; Postmenopause; Treatment Outcome | 2002 |
Postmenopausal women who progress on fulvestrant ('Faslodex') remain sensitive to further endocrine therapy.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Female; Follow-Up Studies; Fulvestrant; Humans; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Retrospective Studies; Salvage Therapy; Treatment Outcome; Triazoles | 2003 |
Phase III, double-blind, controlled trial of atamestane plus toremifene compared with letrozole in postmenopausal women with advanced receptor-positive breast cancer.
Topics: Aged; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Receptors, Steroid; Toremifene; Triazoles | 2007 |
Anastrozole shows evidence of activity in postmenopausal patients who have responded or stabilised on formestane therapy.
Topics: Anastrozole; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Female; Humans; Nitriles; Postmenopause; Prospective Studies; Receptors, Estrogen; Treatment Outcome; Triazoles | 1999 |
5 other study(ies) available for androstenedione and Disease Exacerbation
| Article | Year |
|---|---|
Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues.
Topics: Aged; Androstenedione; Dihydrotestosterone; Disease Progression; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Humans; Hypogonadism; Immunohistochemistry; Male; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testosterone | 2013 |
Virilising adrenocortical tumours in children.
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocortical Adenoma; Adrenocortical Carcinoma; Adrenocorticotropic Hormone; Androstenedione; Biomarkers; Child; Child, Preschool; Dehydroepiandrosterone Sulfate; Diagnostic Errors; Disease Progression; Female; Humans; Immunohistochemistry; Infant; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Mutation; Testosterone; Tomography, X-Ray Computed; Tumor Suppressor Protein p53; Ultrasonography, Interventional; Virilism | 2003 |
Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Hormones; Adult; Androstenedione; Arthritis, Rheumatoid; Dehydroepiandrosterone; Disease Progression; Female; Humans; Hydrocortisone; Kidney; Lupus Erythematosus, Systemic; Male; Middle Aged; Proteinuria | 2004 |
Investigation of oestrogen receptors, sex steroids and soluble adhesion molecules in the progression of malignant melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androstenedione; Cell Adhesion Molecules; Child; Disease Progression; Estrone; Female; Humans; Intercellular Adhesion Molecule-1; Male; Melanoma; Middle Aged; Prospective Studies; Receptors, Estrogen; Retrospective Studies; Sex Characteristics; Skin Neoplasms; Vascular Cell Adhesion Molecule-1 | 1997 |
Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?
Topics: Adult; Aged; Anastrozole; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Disease Progression; Enzyme Inhibitors; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Retrospective Studies; Treatment Failure; Triazoles | 2001 |